Literature DB >> 16734084

Immunoglobulin deficiency in Cavalier King Charles Spaniels with Pneumocystis pneumonia.

P J Watson1, P Wotton, J Eastwood, S T Swift, B Jones, M J Day.   

Abstract

Serum concentrations of immunoglobulin G (IgG), IgM, and IgA were measured in 9 Cavalier King Charles Spaniels with pneumonia caused by Pneumocystis sp that were examined at 4 veterinary surgeries in the United Kingdom (UK) between September 2001 and November 2002. Pneumocystis pneumonia was confirmed in all dogs by visualization of the organism in bronchoalveolar lavage fluid or a transthoracic lung aspirate. Two dogs had a history of demodicosis. Immunoglobulin concentrations also were measured in breed-and age-matched dogs sampled over the same period. IgG concentrations were significantly (P = .000) lower in the affected dogs (median 3.2 mg/mL) than in the control dogs (median 8.5 mg/mL). IgM concentrations were significantly (P = .002) higher in the affected dogs (median 1.95 mg/mL) than in the control dogs (median 1.12 mg/mL). One affected dog had no change in IgG concentration more than 3 months after resolution of infection or vaccination, but did have reduction in IgM concentration after resolution of infection and vaccination. Control dogs had low serum IgG and IgM concentrations, compared with the reference interval for all dogs. Lymphocyte count in blood was normal or high in 7 of 8 affected dogs. The results of this study suggest that there is a defect in immunity in Cavalier King Charles Spaniels that underlies the susceptibility of these dogs to pneumocystosis. Further studies are indicated to elucidate the mechanisms behind the defect, the prevalence within the breed, and the potential mode of inheritance of the problem.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734084     DOI: 10.1892/0891-6640(2006)20[523:idickc]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  8 in total

1.  Common variable immune deficiency in a Pomeranian with Pneumocystis carinii pneumonia.

Authors:  Hideyuki Kanemoto; Rei Morikawa; James Kenn Chambers; Koichi Kasahara; Yasuko Hanafusa; Kazuyuki Uchida; Koichi Ohno; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2015-02-10       Impact factor: 1.267

Review 2.  Canine autoimmune hemolytic anemia: management challenges.

Authors:  James W Swann; Barbara J Skelly
Journal:  Vet Med (Auckl)       Date:  2016-07-26

3.  Nested-polymerase chain reaction detection of Pneumocystis carinii f. sp. canis in a suspected immunocompromised Cavalier King Charles spaniel with multiple infections.

Authors:  Matteo Petini; Tommaso Furlanello; Patrizia Danesi; Andrea Zoia
Journal:  SAGE Open Med Case Rep       Date:  2019-04-26

4.  Hepatic leptospiral infections in dogs without obvious renal involvement.

Authors:  Katie E McCallum; Fernando Constantino-Casas; John M Cullen; James H Warland; Harry Swales; Niamh Linghley; Andre J Kortum; Alex J Sterritt; Tristan Cogan; Penny J Watson
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

5.  Increased prevalence of Borrelia burgdorferi infections in Bernese Mountain Dogs: a possible breed predisposition.

Authors:  Bernhard Gerber; Simone Eichenberger; Max M Wittenbrink; Claudia E Reusch
Journal:  BMC Vet Res       Date:  2007-07-12       Impact factor: 2.741

6.  Quantitative PCR and Cytology of Bronchoalveolar Lavage Fluid in Dogs with Bordetella bronchiseptica Infection.

Authors:  A M Canonne; F Billen; C Tual; E Ramery; E Roels; I Peters; C Clercx
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

Review 7.  Bacterial pneumonia in dogs and cats.

Authors:  Jonathan D Dear
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-01       Impact factor: 2.093

8.  X-linked CD40 ligand deficiency in a 1-year-old male Shih Tzu with secondary Pneumocystis pneumonia.

Authors:  Kristen Merrill; Emily Coffey; Eva Furrow; Isabelle Masseau; Hansjörg Rindt; Carol Reinero
Journal:  J Vet Intern Med       Date:  2020-12-04       Impact factor: 3.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.